BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28778965)

  • 21. Clinical practice. Fibroblast growth factor (FGF)23: a new hormone.
    Alon US
    Eur J Pediatr; 2011 May; 170(5):545-54. PubMed ID: 21193927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions.
    Agoro R; White KE
    Nat Rev Nephrol; 2023 Mar; 19(3):185-193. PubMed ID: 36624273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.
    Küng CJ; Haykir B; Schnitzbauer U; Egli-Spichtig D; Hernando N; Wagner CA
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F785-F798. PubMed ID: 34719948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema.
    Gracia-Iguacel C; Gonzalez-Parra E; Rodriguez-Osorio L; Sanz AB; Almaden Y; de la Piedra C; Egido J; Rodriguez M; Ortiz A
    J Bone Miner Metab; 2013 Nov; 31(6):703-7. PubMed ID: 23677707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system.
    Ohnishi M; Razzaque MS
    Contrib Nephrol; 2013; 180():1-13. PubMed ID: 23652546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.
    Bergwitz C; Jüppner H
    Annu Rev Med; 2010; 61():91-104. PubMed ID: 20059333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation and function of the FGF23/klotho endocrine pathways.
    Martin A; David V; Quarles LD
    Physiol Rev; 2012 Jan; 92(1):131-55. PubMed ID: 22298654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion.
    Galitzer H; Ben-Dov I; Lavi-Moshayoff V; Naveh-Many T; Silver J
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):363-7. PubMed ID: 18660671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
    Fukumoto S
    Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGF23 and Phosphate-Cardiovascular Toxins in CKD.
    Vogt I; Haffner D; Leifheit-Nestler M
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31698866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Regulation of mineral metabolism and mineralization by FGF23].
    Fukumoto S
    Clin Calcium; 2015 May; 25(5):687-91. PubMed ID: 25926572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro.
    Yamamoto R; Minamizaki T; Yoshiko Y; Yoshioka H; Tanne K; Aubin JE; Maeda N
    J Endocrinol; 2010 Sep; 206(3):279-86. PubMed ID: 20530653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Classical Effects of FGF23: Molecular and Clinical Features.
    Martínez-Heredia L; Canelo-Moreno JM; García-Fontana B; Muñoz-Torres M
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A new axis of phosphate balance control: fibroblast growth factor 23-Klotho].
    Prié D; Torres PU; Friedlander G
    Nephrol Ther; 2009 Nov; 5(6):513-9. PubMed ID: 19464978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.